Literature DB >> 27172753

Ovarian large cell neuroendocrine carcinoma in the youngest woman.

Y S Kwon, K S Im, D I Choi.   

Abstract

Large cell neuroendocrine carcinoma (LCNC) of the ovary is a rare tumor in gynecologic oncologic field. An 18-year-old woman presented with abdominal distention and a pelvic mass measuring ten cm in diameter, who previously underwent laparoscopic ovarian cystectomy due to large borderline mucinous ovarian neoplasm 18 months prior. A debulking operation was optimally performed, which included total abdominal hysterectomy with bilateral salpingo-oophorectomy, bilateral pelvic lymph node dissection, bilateral paraaortic lymph node dissection, omentectomy, optimal debulking of gastrohepatic mass and subdiaphragmatic mass, and pelvic peritonectomy. Despite adjuvant chemotherapy with paclitaxel and carboplatin, the patient died of progressive disease seven months after surgery. The authors report the youngest case of LCNC of the ovary, that failed chemotherapy and had the previous history of the conservative surgical treatment due to mucinous borderline tumor.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27172753

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study.

Authors:  Li Pang; Zhiqiang Guo
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 2.  Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors.

Authors:  Sergio Pedraza-Arévalo; Manuel D Gahete; Emilia Alors-Pérez; Raúl M Luque; Justo P Castaño
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

3.  BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea.

Authors:  Do Hoon Kim; Chi Heum Cho; Sun Young Kwon; Nam Hee Ryoo; Dong Seok Jeon; Wonmok Lee; Jung Sook Ha
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.